Skip to main content
. 2021 Oct 20;14:5403–5417. doi: 10.2147/JIR.S331010

Figure 3.

Figure 3

Mutation features of XRCC1 in TCGA-COAD cohort. (A) Alteration frequency of XRCC1 in pan-cancer data. (B) Alteration frequency of XRCC1 in different pathological types of COAD. (C) Alteration frequency of XRCC1 according to mutation type and the mutation site, with the 3D structure of XRCC1. (DF) Relationship of XRCC1 mutation status with disease-free, progression-free, and overall survival in COAD patients. The statistically significant (P value < 0.05).